Esperion Therapeutics
ESPR
#6732
Rank
C$0.68 B
Marketcap
$3.45
Share price
2.49%
Change (1 day)
111.68%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.97 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are C$0.97 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.87 B12.97%
2022-12-31C$0.77 B5.22%
2021-12-31C$0.73 B28.67%
2020-12-31C$0.57 B125.57%
2019-12-31C$0.25 B189.87%
2018-12-31C$87.63 M110.3%
2017-12-31C$41.67 M86.67%
2016-12-31C$22.32 M93.58%
2015-12-31C$11.53 M2.21%
2014-12-31C$11.28 M152.17%
2013-12-31C$4.47 M-81.79%
2012-12-31C$24.56 M193.19%
2011-12-31C$8.37 M
2002-12-31C$20 M6.03%
2001-12-31C$18.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.65 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.00 B 106.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$177.34 B 18,121.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.34 B 1,065.19%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.84 B-12.75%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.18 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA